UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 718

Sortiert nach

Prothrombin and Factor V Mutations in Women with a History of Thrombosis during Pregnancy and the Puerperium

The New England journal of medicine, 2000-02, Vol.342 (6), p.374-380

2000

Link zum Volltext

Verfügbarkeit prüfen

Is There an Overlap between Sudden Neurosensorial Hearing Loss and Cardiovascular Risk Factors?

Audiology & neurotology, 2009-01, Vol.14 (3), p.139-145

2009

Link zum Volltext

Verfügbarkeit prüfen

Acquired platelet function disorders: pathogenesis, classification, frequency, diagnosis, clinical management

Hämostaseologie, 2008-12, Vol.28 (5), p.299

Scharf, R E

2008

Link zum Volltext

Verfügbarkeit prüfen

Hemostatic disorders: clinical management based on molecular mechanisms

Fortschritte der Neurologie-Psychiatrie, 2011-03, Vol.79 (3), p.171

Scharf, R E

2011

Link zum Volltext

Verfügbarkeit prüfen

The impact and management of acquired platelet dysfunction

Hämostaseologie, 2011-01, Vol.31 (1), p.28

2011

Link zum Volltext

Verfügbarkeit prüfen

Platelet pathology and antiplatelet strategies. Resolved and unresolved issues

Hämostaseologie, 2016, Vol.36 (1), p.7

Scharf, R E

2016

Link zum Volltext

Verfügbarkeit prüfen

Von Willebrand factor, hemostasis and inflammation

Hämostaseologie, 2015, Vol.35 (3), p.209

Scharf, R E

2015

Link zum Volltext

Verfügbarkeit prüfen

Rotation thromboelastography (ROTEM) parameters are influenced by age, gender, and oral contraception

Perfusion, 2011-07, Vol.26 (4), p.334-340

2011

Link zum Volltext

Verfügbarkeit prüfen

Rotation thromboelastography for the detection and characterization of lipoteichoid acid-induced activation of haemostasis in an in vitro sepsis model

Perfusion, 2013-03, Vol.28 (2), p.146-151

2013

Link zum Volltext

Verfügbarkeit prüfen

Coagulation disorders - recent lessons from clinical conditions

Hämostaseologie, 2015, Vol.35 (4), p.301

Scharf, R E

2015

Link zum Volltext

Verfügbarkeit prüfen

Pharmacological thromboprophylaxis in gynecology and obstetrics

Hämostaseologie, 2014, Vol.34 (4), p.277

2014

Link zum Volltext

Verfügbarkeit prüfen

Management of acquired haemophilia A

Hamostaseologie, 2015, Vol.35 (4), p.311

2015

Link zum Volltext

Verfügbarkeit prüfen

The G20210A prothrombin‐gene mutation and the plasminogen activator inhibitor (PAI‐1) 5G/5G genotype are associated with early onset of severe preeclampsia

Journal of thrombosis and haemostasis, 2005-04, Vol.3 (4), p.686-691

2005

Link zum Volltext

Verfügbarkeit prüfen

Prospective analysis after coronary-artery bypass grafting: platelet GP IIIa polymorphism (HPA-1b/PIA2) is a risk factor for bypass occlusion, myocardial infarction, and death

Thrombosis and haemostasis, 2000-03, Vol.83 (3), p.404

2000

Link zum Volltext

Verfügbarkeit prüfen

Polymorphism of platelet membrane glycoprotein IIIa: human platelet antigen 1b (HPA-1b/PlA2) is an inherited risk factor for premature myocardial infarction in coronary artery disease

Thrombosis and haemostasis, 1998-04, Vol.79 (4), p.731

1998

Link zum Volltext

Verfügbarkeit prüfen

Management of bleeding in patients using antithrombotic agents: prediction, prevention, protection and problem-oriented intervention

Hämostaseologie, 2009-11, Vol.29 (4), p.388

Scharf, R E

2009

Link zum Volltext

Verfügbarkeit prüfen

Associations between thrombophilic risk factors and determinants of atherosclerosis and inflammation in patients with non-arteritic anterior ischaemic optic neuropathy

Hämostaseologie, 2016, Vol.36 (1), p.46

2016

Link zum Volltext

Verfügbarkeit prüfen

Activation of platelets in blood perfusing angioplasty-damaged coronary arteries. Flow cytometric detection

Arteriosclerosis and thrombosis, 1992-12, Vol.12 (12), p.1475

1992

Link zum Volltext

Verfügbarkeit prüfen

Monitoring of antiplatelet therapy. Current limitations, challenges, and perspectives

Hämostaseologie, 2011-02, Vol.31 (1), p.41

2011

Link zum Volltext

Verfügbarkeit prüfen

Elevated platelet count as a cause of abnormal von Willebrand factor multimer distribution in plasma

Blood, 1993-09, Vol.82 (6), p.1749-1757

1993

Link zum Volltext

Verfügbarkeit prüfen

Antithrombotic prophylaxis for women with thrombophilia and pregnancy complications

Journal of thrombosis and haemostasis, 2004-07, Vol.2 (7), p.1182-1183

2004

Link zum Volltext

Verfügbarkeit prüfen

Thrombophilia and gestational venous thromboembolism

Thrombosis research, 2005-02, Vol.115 Suppl 1, p.99

2005

Link zum Volltext

Verfügbarkeit prüfen

Clinical features and outcome of acquired haemophilia A. Interim analysis of the Düsseldorf study

Hämostaseologie, 2010-08, Vol.30 (3), p.156

2010

Link zum Volltext

Verfügbarkeit prüfen

Genetic typing of human platelet antigen 1 (HPA‐1) by oligonucleotide ligation assay in a specific and reliable semi‐automated system

British journal of haematology, 1997-01, Vol.96 (1), p.198-203

1997

Link zum Volltext

Verfügbarkeit prüfen

The use of LMWH in pregnancies at risk: new evidence or perception?

Journal of thrombosis and haemostasis, 2005-04, Vol.3 (4), p.778-779

WALKER, I. D.

2005

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 718

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(613)
Mit Volltextzugriff
(563)

Publikationsform

2 weitere anzeigen...

Weniger anzeigen...

Sprache

5 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Science & Technology
(395)
Life Sciences & Biomedicine
(332)
Humans
(301)
Female
(153)
Male
(149)
Biological And Medical Sciences
(128)
Adult
(115)
Animals
(100)
Middle Aged
(100)
Medical Sciences
(89)
Aged
(66)
Hematology
(54)
Fundamental And Applied Biological Sciences. Psychology
(51)
Biochemistry & Molecular Biology
(49)
Risk Factors
(39)
Adolescent
(38)
Cardiovascular System & Cardiology
(36)
Technology
(35)
Immunology
(34)
General & Internal Medicine
(32)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Prothrombin and Factor V Mutations in Women with a History of Thrombosis during Pregnancy and the Puerperium

Is There an Overlap between Sudden Neurosensorial Hearing Loss and Cardiovascular Risk Factors?

Acquired platelet function disorders: pathogenesis, classification, frequency, diagnosis, clinical management

Hemostatic disorders: clinical management based on molecular mechanisms

The impact and management of acquired platelet dysfunction

Platelet pathology and antiplatelet strategies. Resolved and unresolved issues

Von Willebrand factor, hemostasis and inflammation

Rotation thromboelastography (ROTEM) parameters are influenced by age, gender, and oral contraception

Rotation thromboelastography for the detection and characterization of lipoteichoid acid-induced activation of haemostasis in an in vitro sepsis model

Coagulation disorders - recent lessons from clinical conditions

Pharmacological thromboprophylaxis in gynecology and obstetrics

Management of acquired haemophilia A

The G20210A prothrombin‐gene mutation and the plasminogen activator inhibitor (PAI‐1) 5G/5G genotype are associated with early onset of severe preeclampsia

Prospective analysis after coronary-artery bypass grafting: platelet GP IIIa polymorphism (HPA-1b/PIA2) is a risk factor for bypass occlusion, myocardial infarction, and death

Polymorphism of platelet membrane glycoprotein IIIa: human platelet antigen 1b (HPA-1b/PlA2) is an inherited risk factor for premature myocardial infarction in coronary artery disease

Management of bleeding in patients using antithrombotic agents: prediction, prevention, protection and problem-oriented intervention

Associations between thrombophilic risk factors and determinants of atherosclerosis and inflammation in patients with non-arteritic anterior ischaemic optic neuropathy

Activation of platelets in blood perfusing angioplasty-damaged coronary arteries. Flow cytometric detection

Monitoring of antiplatelet therapy. Current limitations, challenges, and perspectives

Elevated platelet count as a cause of abnormal von Willebrand factor multimer distribution in plasma

Antithrombotic prophylaxis for women with thrombophilia and pregnancy complications

Thrombophilia and gestational venous thromboembolism

Clinical features and outcome of acquired haemophilia A. Interim analysis of the Düsseldorf study

Genetic typing of human platelet antigen 1 (HPA‐1) by oligonucleotide ligation assay in a specific and reliable semi‐automated system

The use of LMWH in pregnancies at risk: new evidence or perception?

Suchergebnisse filtern